Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2463158A1 Depot formulations of iloperidone and a star polymer
05/08/2003CA2463067A1 Pharmaceutical formulations comprising substituted xanthine compounds
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2462206A1 Substituted thioacetamides
05/08/2003CA2460134A1 Peroxisome proliferator activated receptor ligand and process for producing the same
05/08/2003CA2460118A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/08/2003CA2458850A1 Fibrin nanoparticles and uses thereof
05/08/2003CA2451168A1 Methods for assessing and treating leukemia
05/08/2003CA2450726A1 Cream for treating photoinduced skin damage comprising lipoic acid, coenzyme q-10 and acetyl-l-carnitine
05/08/2003CA2426785A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/07/2003EP1308513A1 Use of polypeptide
05/07/2003EP1308500A1 Ophthalmic composition
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1308457A1 Ribosome structure and protein synthesis inhibitors
05/07/2003EP1308448A1 Method for the preparation of chromanone
05/07/2003EP1308447A1 Purine derivatives having antiproliferative properties and biological uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308444A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha Levels
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308179A1 Improved endoprosthetic device
05/07/2003EP1308171A1 Pharmaceutical compositions containing dds compounds
05/07/2003EP1308169A1 Reservoir composition for the topical application of sparingly soluble drugs, their production and use
05/07/2003EP1308164A2 Medical composition comprising a polysaccharide for elevating the epithelium
05/07/2003EP1308163A1 Endoparasiticidal gel composition
05/07/2003EP1308162A1 Pernasal preparation
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308160A1 Highly absorbable solid preparation
05/07/2003EP1308159A1 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1308084A1 Synergistic UV absorber combination
05/07/2003EP1307594A1 Association of sim2 with cancer
05/07/2003EP1307580A1 Koji molds and use thereof for preparing cholesterol-lowering products
05/07/2003EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307565A2 Vaccination against host cell-associated herpesviruses
05/07/2003EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/07/2003EP1307539A2 Gene expression profile for kshv infection and methods for treating same
05/07/2003EP1307491A1 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
05/07/2003EP1307472A1 Peptides capable of functioning as mimotopes for estradiol analytes
05/07/2003EP1307471A1 16alpha-methyl or ethyl substituted estrogens
05/07/2003EP1307468A1 Macrolide antibiotics
05/07/2003EP1307463A1 Pyrrolo 2,1-b]-[1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307461A2 Substituted pyrrole compounds and their use as spla2 inhibitors
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP1307459A2 Indole compounds useful for the treatment of cancer
05/07/2003EP1307458A1 Pyrrolotriazolopyrimidinone derivatives
05/07/2003EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
05/07/2003EP1307456A1 Imidazo-pyrazine derivatives as ligands for gaba receptors
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307454A1 Derivatives of variolin b
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307452A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307448A1 Tartrate salts of thiazolidinedione derivative
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307445A1 Benzofuran derivatives and their use as antibacterial agents
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307442A2 Method for producing lipoic acid and dihydrolipoic acid
05/07/2003EP1307441A1 1,3-dioxolanes with antitussive activity
05/07/2003EP1307440A1 2,2-disubstituted 1,3-dioxolanes as antitussive agents
05/07/2003EP1307439A2 Synthetic salicylihalamides, apicularens and derivatives thereof
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307436A1 Process for the preparation of baccatin iii derivatives
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307264A2 New pharmaceutical composition
05/07/2003EP1307263A2 New use of lipase inhibitors
05/07/2003EP1307245A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
05/07/2003EP1307243A2 A medicinal aerosol formulation
05/07/2003EP1307233A2 Therapeutic polyanhydride compounds for drug delivery
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307227A2 Pharmaceutical compositions
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307220A1 Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
05/07/2003EP1307218A1 Obesity controlling method
05/07/2003EP1307213A2 Chlorella preparations exhibiting immunomodulating properties
05/07/2003EP1307209A1 Cardioplegic solution
05/07/2003EP1307207A1 Extended type 1 chain glycosphingolipids as tumor-associated antigens
05/07/2003EP1307206A2 Method for enhancing bone mineral density gain by administration of raloxifene
05/07/2003EP1307205A2 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1307202A1 Method for the treatment of overactive bladder
05/07/2003EP1307201A2 Selective pde 2 inhibitors, used as medicaments for improving cognition
05/07/2003EP1307200A2 Substituted-triazolopyrimidines as anticancer agents
05/07/2003EP1307199A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
05/07/2003EP1307198A1 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase
05/07/2003EP1307197A2 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP1307195A2 Medicaments containing cilansetron for treating non-obstipated male ibs patients
05/07/2003EP1307194A1 Fentanyl composition for nasal administration
1 ... 5477 5478 5479 5480 5481 5482 5483 5484 5485 5486 5487 5488 5489 5490 5491 5492 5493 5494 5495 5496 5497 ... 7860